Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia

Published:2005-01 Issue:1 Volume:36 Page:91-100
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Lugli Alessandro,Ebnoether Monika,Cogliatti Sergio B.,Gratwohl Alois,Passweg Jakob,Hess Urs,Korte Wolfgang,Hawle Hanne,Tinguely Marianne,Borisch Bettina,Mach-Pascual Sara,Von Juergensonn Silke,Tichelli André,Dirnhofer Stephan

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference28 articles.

1. Chronic myeloid leukemia;Sawyers;N. Engl. J. Med.,1999

2. Biology of chronic myelogenous leukemia;Verfaillie;Hematol. Oncol. Clin. North Am.,1998

3. Cell biology of CML cells;Gordon;Leukemia,1999

4. Imatinib mesylate—the new gold standard for treatment of chronic myeloid leukemia;Peggs;N. Engl. J. Med.,2003

5. Imatinib for chronic myelogenous leukaemia: a 9 or 24 carat gold standard?;Sausville;Lancet,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of pre-treatment bone marrow morphology and achievement of BCR-ABL1 transcript milestones in CML;Pathology - Research and Practice;2023-06

2. Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia;Advances in Hematology;2019-01-01

3. Synoptic Bone Marrow Reporting;Diagnostic Pathology: Blood and Bone Marrow;2018

4. Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center;Archives of Pathology & Laboratory Medicine;2016-02-23

5. Bone marrow fibrosis may be an effective independent predictor of the ‘TKI drug response level’ in chronic myeloid leukemia;Hematology;2014-12-17